Liquid Biopsy Market size is expected to reach at USD 9.63 Bn. and is grow at a CAGR of 20.9% through the forecast period.

Maximize Market Research, has published market intelligence and competitive landscape report on the Liquid Biopsy Market.

Over the forecast period, 𝐋𝐢𝐪𝐮𝐢𝐝 𝐁𝐢𝐨𝐩𝐬𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 is expected to grow from USD 2.55 Bn. to USD 9.63 Bn. by 2030, at a CAGR of 20.9 per cent.

𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 region is dominating the liquid biopsy market with a 51% share. Due to higher investments and the existence of numerous biotechnology businesses producing the tests, the U.S. dominates the regional market. Liquid biopsy is supported by several organizations, including the American Society of Clinical Oncology (ASCO). In consequence, it is expected that this will accelerate sales growth in this area.

𝐆𝐞𝐭 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐅𝐫𝐞𝐞 𝐑𝐢𝐠𝐡𝐭 𝐇𝐞𝐫𝐞: https://www.maximizemarketresearch.com/request-sample/3261/

𝐃𝐫𝐢𝐯𝐞𝐫𝐬 𝐨𝐟 𝐋𝐢𝐪𝐮𝐢𝐝 𝐁𝐢𝐨𝐩𝐬𝐲 𝐌𝐚𝐫𝐤𝐞𝐭:

Rising incidence and prevalence of cancer: The number of persons who have cancer has significantly increased on a world basis. Environmental factors, cigarette use, infectious diseases like Hepatitis B and C, as well as lifestyle changes, are some of the causes of the increased incidence of cancer. Cancer is the second-leading cause of mortality worldwide, according to the WHO. According to estimates from the International Agency for Research on Cancer (IARC), there would be 19.3 million new cases of cancer and 9.96 million cancer-related deaths worldwide in 2022.

𝐋𝐢𝐪𝐮𝐢𝐝 𝐁𝐢𝐨𝐩𝐬𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐭𝐫𝐚𝐢𝐧𝐭𝐬:

The lower sensitivity of certain liquid biopsies: The quantities of ctDNA of any particular cancer mutation may be very low in the plasma of a cancer patient, especially after treatment or surgery, making the detection of ctDNA in liquid biopsies technically tricky. According to sampling statistics, there may be less than one detectable copy of the cancer mutation-containing ctDNA in any one patient's plasma sample.

𝐕𝐢𝐞𝐰 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐕𝐞𝐫𝐬𝐢𝐨𝐧 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞: https://www.maximizemarketresearch.com/request-sample/3261/

𝐋𝐢𝐪𝐮𝐢𝐝 𝐁𝐢𝐨𝐩𝐬𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:

𝐁𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭

• Assay Kits
• Instruments

𝐁𝐲 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲

• Multi-gene-parallel Analysis (NGS)
• Single Gene Analysis (PCR Microarrays)

𝐁𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧

• Cancer
• Non- Cancer

𝐁𝐲 𝐄𝐧𝐝 𝐔𝐬𝐞𝐫

• Reference Lab
• Hospitals

𝐋𝐢𝐪𝐮𝐢𝐝 𝐁𝐢𝐨𝐩𝐬𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐚𝐫𝐞:

1. F. Hoffmann-La Roche Ltd. (Switzerland)
2. Myriad Genetics, Inc. (US)
3. QIAGEN N.V. (Netherlands)
4. Thermo Fisher Scientific, Inc. (US)
5. Guardant Health, Inc. (US)
6. MDxHealth SA (Belgium)
7. Exact Sciences Corporation (US)
8. Illumina Inc. (US)
9. Sysmex Inostics (US)
10. Bio-Rad Laboratories, Inc. (US)
11. Biocept, Inc. (US)
12. NeoGenomics, Inc. (US)
13. ANGLE plc. (UK)

𝐕𝐢𝐞𝐰 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐕𝐞𝐫𝐬𝐢𝐨𝐧 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞: https://www.maximizemarketresearch.com/request-sample/3261/

𝐊𝐞𝐲 𝐪𝐮𝐞𝐬𝐭𝐢𝐨𝐧𝐬 𝐚𝐧𝐬𝐰𝐞𝐫𝐞𝐝 𝐢𝐧 𝐋𝐢𝐪𝐮𝐢𝐝 𝐁𝐢𝐨𝐩𝐬𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐚𝐫𝐞:

1] What segments are covered in the Global Liquid Biopsy Market report?
2] Which region is expected to hold the highest share in the Global Liquid Biopsy Market?
3] What is the market size of the Global Liquid Biopsy Market by 2030?
4] What is the forecast period for the Global Liquid Biopsy Market?
5] What was the market size of the Global Liquid Biopsy Market in 2023?

𝐊𝐞𝐲 𝐎𝐟𝐟𝐞𝐫𝐢𝐧𝐠𝐬:

Past Market Size and Competitive Landscape (2018 to 2023)
Past Pricing and price curve by region (2018 to 2023)
Market Size, Share, Size & Forecast by Different Segment | 2024-2030
Market Dynamics - Growth Drivers, Regional analysis, Segment Analysis, Competitive landscape
Market Segmentation - A detailed analysis of the Offerings, Vertical, Application and Region
Competitive Landscape - Profiles of selected key players by region from a strategic perspective
PESTLE Analysis
PORTER's analysis
Value chain and supply chain analysis
Legal Aspects of business by region

𝐌𝐚𝐱𝐢𝐦𝐢𝐳𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐡𝐚𝐬 𝐚𝐥𝐬𝐨 𝐩𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐝 𝐫𝐞𝐩𝐨𝐫𝐭𝐬 𝐫𝐞𝐥𝐚𝐭𝐞𝐝 𝐭𝐨 𝐋𝐢𝐪𝐮𝐢𝐝 𝐁𝐢𝐨𝐩𝐬𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐚𝐫𝐞:

• 𝐁𝐢𝐨𝐩𝐬𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 size is expected to grow from US$ 32.38 Bn in 2023 to US$ 67.83 Bn by 2030. The Global Biopsy Market is expected to grow at a CAGR of 11.14% through the forecast period (2024 to 2030). https://www.maximizemarketresearch.com/market-report/global-biopsy-market/116684/

• 𝐆𝐥𝐨𝐛𝐚𝐥 𝐁𝐫𝐞𝐚𝐬𝐭 𝐂𝐚𝐧𝐜𝐞𝐫 𝐋𝐢𝐪𝐮𝐢𝐝 𝐁𝐢𝐨𝐩𝐬𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 is projected to grow from USD 470.26 Mn. in 2023 to USD 1671.22 Mn. by 2030, at a CAGR of 19.86% during the forecast period. https://www.maximizemarketresearch.com/market-report/breast-cancer-liquid-biopsy-market/12622/

𝐎𝐮𝐫 𝐀𝐝𝐝𝐫𝐞𝐬𝐬:

𝐌𝐚𝐱𝐢𝐦𝐢𝐳𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐏𝐯𝐭. 𝐋𝐭𝐝.
⮝ 3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
✆ +91 9607365656
🖂 sales@maximizemarketresearch.com
🌐 www.maximizemarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐌𝐚𝐱𝐢𝐦𝐢𝐳𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

This release was published on openPR.